Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation, Panel C, Funding Opportunity Announcement (FOA) PAR07-231, 16877 [E9-8333]

Download as PDF Federal Register / Vol. 74, No. 69 / Monday, April 13, 2009 / Notices both CDC and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: April 7, 2009. Elaine L. Baker, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–8330 Filed 4–10–09; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation, Panel C, Funding Opportunity Announcement (FOA) PAR07–231 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 9 a.m.–5 p.m., April 28, 2009 (Closed). 9 a.m.–5 p.m., April 29, 2009 (Closed). Place: W Hotel, 188 14th Street, NE., Atlanta, Georgia 30361, Telephone: (404) 892–6000. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘CDC Grants for Public Health Research Dissertation, Panel C, FOA PAR07– 231.’’ Contact Person for More Information: Christine J. Morrison, PhD, Scientific Review Officer, Office of the Director, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 7, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–8333 Filed 4–10–09; 8:45 am] VerDate Nov<24>2008 18:51 Apr 10, 2009 Jkt 217001 Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention Times and Dates: 9 a.m.–5 p.m., May 14, 2009. 8:30 a.m.–3:30 p.m., May 15, 2009. Place: CDC Global Communication Center, Building 19, 1600 Clifton Road, NE., Atlanta, Georgia 30333. May 14, 2009—Building 19; Working Groups will meet as follows: Rooms 245/246—The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). Rooms 247/248—National Center for Zoonotic, Vector-Borne, and Enteric Diseases (NCZVED). Rooms 254/255—National Center for Immunization and Respiratory Diseases (NCIRD). Rooms 256/257—National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID). May 15, 2009—Full Board meets in Auditorium B3. Status: Open to the public, limited only by the space available. Purpose: The Board of Scientific Counselors, CCID, provides advice and guidance to the Director, CDC, and Director, CCID, in the following areas: program goals and objectives; strategies; program organization and resources for infectious disease prevention and control; and program priorities. Matters to be Discussed: Agenda items will include: 1. Breakout Group Discussions: Environmental Microbiology—morning session (NCPDCID and NCZVED). 2. Strategic Plan (NCPDCIC)—afternoon session. 3. Strategic Blueprint (NCZVED)— afternoon session. 4. Strategic Plan (NCHHSTP). 5. Prevention of Neonatal Group B Streptococcal Disease Influenza at the Human-Animal Interface; Review of Recommendations from April 2009 Meeting—(NCIRD). 6. Strategies for Infectious Diseases; Positioning for the Future (Full Board). 7. Budget and CCID/OD Updates. Other agenda items include announcements/introductions; follow-up on actions recommended by the Board and consideration of future directions, goals, and recommendations. Agenda items are subject to change as priorities dictate. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 16877 Written comments are welcome and should be received by the contact person listed below prior to the opening of the meeting. Contact Person for More Information: Harriette Lynch, Office of the Director, CCID, CDC, Mailstop E–77, 1600 Clifton Road, N.E., Atlanta, Georgia 30333, e-mail: hlynch@cdc.gov; telephone (404) 498–2726. The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 6, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–8342 Filed 4–10–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director, Centers for Disease Control (ACD, CDC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC announces the following meeting of the aforementioned committee: Time and Date: 8 a.m.–3:30 p.m., April 30, 2009. Place: Centers for Disease Control and Prevention, Tom Harkin Global Communications Center, Kent ‘‘Oz’’ Nelson Auditorium, 1600 Clifton Road, NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 150 people. Purpose: The committee will provide advice to the Director, CDC on strategic and other broad issues facing CDC. Matters To Be Discussed: The committee will discuss the final report on the recommendations from the National Biosurveillance Advisory Subcommittee; discuss the mission of the Health Disparities Subcommittee; discuss the recommendations from the Ethics Subcommittee on the ‘‘Ethical Aspects of Compulsory Use of Travel Restriction Tools’’, and the subcommittee’s input on the ‘‘Role of Social Determinants Health in Health Reform’’; and will discuss CDC’s Organizational Review. Agenda items are subject to change as priorities dictate. For Further Information Contact: Brad Perkins, M.D., M.B.A., ACD, CDC, 1600 Clifton Road, NE., M/S D–14, Atlanta, Georgia 30333. Telephone 404–639–7000. The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices E:\FR\FM\13APN1.SGM 13APN1

Agencies

[Federal Register Volume 74, Number 69 (Monday, April 13, 2009)]
[Notices]
[Page 16877]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-8333]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): CDC Grants for Public Health Research 
Dissertation, Panel C, Funding Opportunity Announcement (FOA) PAR07-231

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date:
    9 a.m.-5 p.m., April 28, 2009 (Closed).
    9 a.m.-5 p.m., April 29, 2009 (Closed).
    Place: W Hotel, 188 14th Street, NE., Atlanta, Georgia 30361, 
Telephone: (404) 892-6000.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
``CDC Grants for Public Health Research Dissertation, Panel C, FOA 
PAR07-231.''
    Contact Person for More Information: Christine J. Morrison, PhD, 
Scientific Review Officer, Office of the Director, Office of the 
Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D72, 
Atlanta, GA 30333, Telephone: (404) 639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 7, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-8333 Filed 4-10-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.